Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)
Fennec Pharmaceuticals' (FENC) quarterly Capital Expenditures came in at $1.7 million in Q1 2024.
Fennec Pharmaceuticals (FENC) Capital Expenditures (2024) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 1 years of Capital Expenditures data on file, last reported at $1.7 million in Q1 2024.
- Quarterly Capital Expenditures changed N/A year-over-year to $1.7 million in Q1 2024, while the trailing twelve-month figure through Jun 2024 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.8 million, changed N/A from the prior year.
- Capital Expenditures was little changed at $1.7 million in Q1 2024.
- In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q1 2024 to a low of $1.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.74 Mn |